Compounds > n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide

n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and inogatran

n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide has been researched along with inogatran in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deinum, J; Nilsson, T; Sjöling-Ericksson, A1

Other Studies

1 other study(ies) available for n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and inogatran

ArticleYear
The mechanism of binding of low-molecular-weight active site inhibitors to human alpha-thrombin.
    Journal of enzyme inhibition, 1998, Volume: 13, Issue:1

    Topics: Antithrombins; Area Under Curve; Arginine; Azetidines; Benzylamines; Binding Sites; Dipeptides; Fluorescence; Glycine; Humans; Kinetics; Molecular Weight; Pipecolic Acids; Piperidines; Spectrometry, Fluorescence; Spectrophotometry; Sulfonamides; Thrombin

1998